Generic name: daridorexant 25mg
Dosage form: tablet, film coated
Drug class: Miscellaneous anxiolytics, sedatives and hypnotics
Medically reviewed by Drugs.com. Last updated on Nov 2, 2023.
The recommended dosage range is 25 mg to 50 mg of QUVIVIQ taken orally no more than once per night within 30 minutes of going to bed (with at least 7 hours remaining prior to planned awakening).
Time to sleep onset may be delayed if taken with or soon after a meal [see Clinical Pharmacology (12.3)].
Dosage Recommendations for Concomitant Use with CYP3A4 Inhibitors or CYP3A4 Inducers
Co-administration with Strong CYP3A4 Inhibitors
Co-administration with Moderate CYP3A4 Inhibitors
Co-administration with Strong or Moderate CYP3A4 Inducers
Avoid concomitant use of QUVIVIQ with strong or moderate CYP3A4 inducers [see Drug Interactions (7.1)].
Dosage Recommendations for Patients with Hepatic Impairment
The maximum recommended dosage in patients with moderate hepatic impairment (Child-Pugh score 7–9) is 25 mg of QUVIVIQ no more than once per night [see Use in Specific Populations (8.6), Clinical Pharmacology (12.3)].
QUVIVIQ is not recommended in patients with severe hepatic impairment (Child-Pugh score ≥ 10) [see Use in Specific Populations (8.6)].
Frequently asked questions
More about Quviviq (daridorexant)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (112)
- Drug images
- Side effects
- During pregnancy
- FDA approval history
- Drug class: miscellaneous anxiolytics, sedatives and hypnotics
- En español
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.